Varenicline Tablet, Film Coated
Product Images NDC 50090-6446

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Varenicline (NDC 50090-6446). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A bar chart titled 'Continuous Abstinence, Weeks 9 through 12' showing percentage data for different treatments across five studies. Treatments include Varenicline 0.5 mg, Varenicline 1.0 mg bid, Placebo, Varenicline Flexible, Bupropion SR 150 mg bid, and Placebo. The chart compares continuous abstinence percentages with error bars for each treatment group in studies labeled 2 through 5.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A bar chart titled 'Continuous Abstinence, Weeks 9 through 52' comparing percentages of continuous abstinence across different studies and treatments. The x-axis lists study names and treatments including Varenicline 0.5 mg BID, Varenicline 1.0 mg BID, Varenicline Flexible, Bupropion SR 150 mg BID, and Placebo. The y-axis shows percentage values from 0% to 35%. Bars indicate the abstinence percentages with error bars for each treatment group.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A line graph comparing the percentage of continuous abstinent individuals over nontreatment follow-up weeks between two groups: Varenicline 1.0 mg twice daily and placebo. The x-axis represents weeks of follow-up, and the y-axis represents percent continuous abstinent.*
FDA Label Image

Label Image (Lbl500906446)

Label Image (Lbl500906446)
VARENICLINE 1 mg film-coated tablet label from A-S Medication Solutions. The oral prescription drug label lists the active ingredient as varenicline tartrate equivalent to 1 mg varenicline free base. The package contains 56 tablets and instructs storage at 68 to 77 degrees Fahrenheit. The label includes the product NDC 50090-6446.*
FDA Label Image

Structure-1 (Structure 1)

Structure-1 (Structure 1)
Chemical structure diagram of the active ingredient varenicline, showing its molecular components and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.